公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2018 | Efficacy and toxicity of pegylated liposomal doxorubicin-based chemotherapy in early-stage breast cancer: a multicenter retrospective case–control study | Yang F.O.; Hsu N.C.; Moi S.-H.; Lu Y.-C.; Hsieh C.-M.; KING-JEN CHANG ; Chen D.-R.; Tu C.-W.; Wang H.-C.; Hou M.-F. | Asia-Pacific Journal of Clinical Oncology | 8 | 7 | |
2014 | EORTC QLQ-BM22 quality of life evaluation and pain outcome in patients with bone metastases from breast cancer treated with zoledronic acid | Yeh D.-C.; Chen D.-R.; Chao T.-Y.; Chen S.-C.; Wang H.-C.; Rau K.-M.; Feng Y.-H.; Chang Y.-C.; Lee K.-D.; Ou-Yang F.; WEN-HUNG KUO ; KING-JEN CHANG ; Lin Y.-C.; Tseng L.-M.; Hou M.-F. | In Vivo | 6 | 7 | |
2010 | Optimal two-stage breast cancer screening for countries with intermediate or low incidence of breast cancer | Kuo S.-J.; Chen, Tony Hsiu Hsi ; Yen A.M.-F.; Chen D.-R.; Chen L.-S. | Journal of Evaluation in Clinical Practice | 1 | 1 | |
2016 | Pegylated Liposomal Doxorubicin as Adjuvant Therapy for Stage I-III Operable Breast Cancer | Lu Y.-C.; Ou-Yang F.U.; Hsieh C.-M.; KING-JEN CHANG ; Chen D.-R.; Tu C.-W.; Wang H.-C.; Hou M.-F. | In vivo (Athens, Greece) | 7 | 0 | |
2011 | Phase II study of docetaxel, capecitabine, and cisplatin as neoadjuvant chemotherapy for locally advanced breast cancer | YEN-SHEN LU ; Chen D.-R.; Tseng L.-M.; Yeh D.-C.; Chen S.-T.; Hsieh C.-M.; Wang H.-C.; Yeh H.-T.; SUNG-HSIN KUO ; CHIUN-SHENG HUANG | Cancer Chemotherapy and Pharmacology | 10 | 8 | |
2012 | A phase II study of neoadjuvant chemotherapy with docetaxel, cisplatin and trastuzumab for T2 breast cancers | Lin C.; Chen D.-R.; KING-JEN CHANG ; Chang T.-W.; Wang H.-C. | Cancer Chemotherapy and Pharmacology | 11 | 11 | |
2013 | Quality of life assessment in Taiwanese patients with bone metastases from breast cancer receiving zoledronic acid | Chao T.-C.; Chen D.-R.; Chao T.-Y.; Chen S.-C.; Yeh D.-C.; Wang H.-C.; Huang W.-T.; Rau K.-M.; KING-JEN CHANG ; Yang T.-L.; Lee K.-D.; Tai C.-J.; Tseng L.-M.; Hou M.-F. | Anticancer Research | 1 |